Skip to content

Regenerative Ability of TAMP BG and BD in Pulpotomized Primary Teeth

Comparison of the Regenerative Ability of Tailored Amorphous Multiporous Bioglass and Biodentine in Pulpotomized Primary Teeth

Status
Terminated
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03786302
Enrollment
102
Registered
2018-12-26
Start date
2016-12-06
Completion date
2018-10-20
Last updated
2020-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulpotomy

Keywords

TAMP BG, Biodentine, Regenerative materials, pulp therapy

Brief summary

The aim of this study was to assess clinically, radiographically, and histologically the regenerative ability of Tailored Amorphous Mulioporous (TAMP-BG) bioglass in comparison to Biodentine™ (BD) in pulpotomized primary teeth.

Detailed description

The study was a parallel design, randomized controlled clinical trial It was conducted in the out-patient clinic of the Pediatric Dentistry and Dental public health department after obtaining the guardians consent. The sample size was calculated to be 35 teeth per group. The teeth were randomly and equally assigned to either BD or TAMP-BG groups.The treatment follow-up was scheduled at 1, 3, 6, 9 and 12 months. The study was terminated for ethical considerations after showing significant clinical failure in the TAMP-BG group and after performing interim analysis.

Interventions

DRUGTAMP bioglass

TAMP bioglass compared to Biodentine in the regeneration on pulpotomized primary teeth

DRUGBiodentine

TAMP bioglass compared to Biodentine in the regeneration on pulpotomized primary teeth

Sponsors

Alexandria University
CollaboratorOTHER
Nourhan M.Aly
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Masking description

The operator will not be blinded to the treatment type. However, the participants, their care givers, the expert assessing the histologic and inflammatory changes and the statistician will be blinded to the treatment groups.

Intervention model description

Study group (assigned to TAMP bioglass), and Control group (assigned to Biodentine ™).

Eligibility

Sex/Gender
ALL
Age
5 Years to 9 Years
Healthy volunteers
No

Inclusion criteria

* Children free of any systemic disease or special health care needs. * Children not receiving any anti-inflammatory medication. * Cooperative children (positive/ definitely positive) according to Frankl's behavior rating scale. * Restorable teeth. * Teeth with vital carious pulp exposure that will bleed upon entering the pulp chamber and not requiring more than 5 minutes to achieve hemostasis after coronal pulp amputation. * Teeth indicated for extraction for orthodontic purposes with the previously mentioned criteria (required for a subgroup for assessment of histological and inflammatory response outcomes).

Exclusion criteria

* Teeth with clinical or radiographic signs of pulp degeneration.

Design outcomes

Primary

MeasureTime frameDescription
Absence of clinical signs of pulp degeneration.1 month postoperativelyTeeth were considered clinically successful when they showed no signs of pain, sensitivity to percussion, swelling, fistula or pathologic mobility
Percentage of Teeth with no clinical signs of pulp degeneration.3 months postoperativelyTeeth were considered clinically successful when they showed no signs of pain, sensitivity to percussion, swelling, fistula or pathologic mobility
Percentage of Teeth with no radiographic signs of pulp degeneration.6 months postoperativelyDigital postoperative periapical radiographs were obtained and assessed for signs of pulp degeneration. Teeth were considered radiographically successful when they showed no periapical or interradicular radiolucency, abnormal root resorption or periodontal ligament space widening

Secondary

MeasureTime frameDescription
Percentage of teeth with radiographic evidence of dentin bridge formation6 months postoperativelyAssessed using digital radiographs
Dentin bridge formation using light microscopy6 weeksAfter tooth extraction, histological assessment will be done according to Horsted et al's (1981) and Shayegan et al's (2012) modified criteria. 0= No hard tissue formation. 1. Incomplete hard tissue formation. 2. Thick hard tissue formation.
Inflammatory response using light microscopy6 weeksAfter tooth extraction, histological assessment will be done according to Horsted et al's (1981) and Shayegan et al's (2012) modified criteria. A. Inflammatory cell response: 0= None or a few scattered inflammatory cells beneath the site of pulp exposure. 1. Mild inflammatory cells (either acute or chronic). 2. Moderate inflammatory cell infiltration involving the cervical third of radicular pulp. 3. Severe inflammatory cell infiltration involving the coronal third of radicular pulp. B. Tissue disorganization: 0= Normal tissue beneath the site of pulp exposure. 1. Odontoblast-like cells, odontoblasts, and pulp tissue pattern disorganization. 2. General disorganization of the pulp tissue pattern. 3. Pulp necrosis.
The Enzyme-Linked Immunosorbent Assay (ELISA) analysis.6 weeksAfter extraction, the tooth will be sectioned under copious water cooling and all remaining pulp tissue will be harvested gently from the radicular portion and stored until the time of assaying. For the ELISA assaying, the frozen pulp samples will be thawed for 15 minutes, and crushed with a glass rod in the eppendorf tube to elute the cytokines from the pulp tissue. IL-8 and IL-10 will be measured using ElISA Kits according to the instructions supplied with the kit and the ratio of IL-8/IL-10 will be taken as an indicator of pulpal inflammation. Cytokines' concentration will be calculated according to the weight of the pulp tissue.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026